Indian Journal of Obstetrics and Gynecology Research

Print ISSN: 2394-2746

Online ISSN: 2394-2754

CODEN : IJOGCS

Indian Journal of Obstetrics and Gynecology Research (IJOGR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 461

PDF Downloaded: 512


Get Permission Thilak, Harika, and Narayanswamy: The serum leptin can be a predictable marker for gestational diabetes mellitus


Introduction

Gestational Diabetes Mellitus (GDM) is one of the most prevalent conditions associated with pregnancy, and if untreated it can have a major negative impact on both the mother's and the child's health.1, 2 It affects 3-8% of pregnancies and is defined by glucose intolerance identified during pregnancy due to obesity risk. Around thirteen to fourteen (13-14%) of pregnant women are getting converted to GDM and it is characterized insulin resistance and b-cell dysfunction.3, 4 The etiology of GDM remains poorly understood. The most widely accepted explanation states that human placental lactogen, prolactin, glucocorticoids, and progesterone all of which are released by the placenta during pregnancy cause GDM by lowering insulin sensitivity and boosting anti-insulin hormones.5

Adipocytes produce adipocytokines likes leptin that contribute to energy balance, metabolism of glucose and insulin. According to certain research, leptin may also play a major role in controlling the body's overall glucose homeostasis. Leptin may therefore play a significant role in the onset and prognosis of GDM.6 According to certain research, there is a favorable relationship between plasma leptin concentrations and both direct and indirect markers of obesity. Leptin levels rise in expectant mothers who have altered maternal fat reserves and glucose metabolism. The concentration of leptin in mothers rises two to three times higher than in non-pregnant women, peaking at 28 weeks of gestation.7, 8

According to certain clinical research, that an increase of adipocyte leptin production in the context of rising insulin resistance and hyperinsulinemia in the second half of pregnancy may be the cause of rising maternal plasma leptin.9 Studies have demonstrated that leptin directly influences the body's sensitivity to insulin by controlling the skeletal muscle's ability to utilize insulin to metabolize glucose and by controlling the liver's gluconeogenesis.10, 11, 12 According to certain research, leptin has an immediate inhibitory effect on insulin secretion. Vast epidemiological investigations have demonstrated a favorable correlation between men's and non-pregnant women's plasma leptin concentrations and insulin resistance.13, 14 All things considered, the information at hand points to a complicated relationship between human glucose homeostasis and leptin.15 To the best of our knowledge, maternal leptin concentrations in women with GDM have only been investigated by two research teams, and the associated published results are inconsistent. However, it is unclear from the data at hand whether the changes in leptin concentrations are a cause or an effect of the inherent metabolic abnormalities associated with GDM. Hence, the present study aimed to evaluate the role of serum leptin in patients with gestational diabetes mellitus.

Materials and Methods

This case control study conducted at the Haveri Institute of Medical Sciences, Haveri, Karnataka between December 2022 to January 2024. A total sixty (n=60) patients diagnosed with gestational diabetes mellitus (GDM) and sixty (n=60) healthy volunteers were considered as controls.

Inclusion criteria

The study subjects age between 20 to 35 and diagnosed with gestational diabetes mellitus according to International Diabetic Federation (IDF) criteria.

Exclusion criteria

The subjects with other types of diabetes, Non-Diabetic Renal Disease, Urinary Tract Infections, Thyroid and liver disease, Macrovascular complications such as cardiovascular, cerebrovascular and peripheral vascular diseases and whoever is not willing to participate in the study were excluded. The study was conducted after approval of Institutional Ethics Committee (IEC) and also the study participants was recruited after informed consent form.

Seven (7) ml of overnight fasting blood sample was collected from all the subjects into two tubes: 2 ml transferred into a fluoride tube, 2 ml transferred into ethylene diamine tetra acetic acid and remaining 3 ml transferred into plain tube. The plasma and serum samples were separated by using centrifuge 3000 rpm for 10 mins and immediately transferred into properly labelled aliquots until analysis was done.

The fasting blood sugars (FBS) was estimated by using glucose oxidase peroxidase method, triglycerides (TGL), total cholesterol (TC), was analyzed by enzymatic method, high density lipoprotein was determined by using selective inhibitory method, very low-density lipoproteins and low-density lipoproteins were calculated by friedewald’s formula. The serum leptin concentrations were determined by enzyme linked immunosorbent assay.

Statistical analysis

For continuous data, the presentation of characteristics was represented mean and standard deviation (SD). The comparison between the groups by using analysis of variance (ANOVA). The Pearson’s correlation analysis was used to correlate between the variables and the scatter plots was constructed between the variables. The microsoft excel spread sheets and SPSS windows version 20.0. The P-value is < 0.05 considered statistically significant.

Results

Table 1 shows the comparison of study variables between the cases and controls. The age and BMI showed a statistically significant between cases and controls (P=0.001**). There is a significantly increased levels of FBS, HbA1c, total cholesterol and LDL in cases when compared to controls (P=0.001**). The significant increase levels of serum Leptin in cases is observed when compared to controls (P=0.001**). Additionally, TGL, HDL and VLDL are not showing significant values between cases and controls.

Table 1

Comparison of study variables between the cases and controls

Parameters

Controls

Cases

P-Values

Age

25.45

±

2.53

30.77

±

2.35

0.001**

BMI

22.75

±

2.00

35.09

±

2.57

0.001**

FBS

98.12

±

8.52

169.65

±

73.13

0.001**

HbA1c

4.25

±

0.50

8.68

±

0.40

0.001**

TGL

186.30

±

39.28

194.18

±

59.61

0.394

TC

150.53

±

26.11

223.98

±

126.73

0.001**

HDL

37.98

±

10.89

38.25

±

8.71

0.882

VLDL

37.26

±

7.86

38.84

±

11.92

0.394

LDL

75.29

±

29.84

146.90

±

126.96

0.001**

Serum Leptin

9.68

±

3.74

35.10

±

4.35

0.001**

Table 2 shows the correlation of serum leptin with study variables. The serum Leptin was positively correlated with BMI, FBS, HbA1C, TC and LDL. There is no significant correlation between Leptin and TGL, HDL, VLDL.

Table 2

Correlation of serum leptin with other study variables

Parameter

Leptin

R

P

BMI

0.888

0.001**

FBS

0.531

0.001**

HbA1c

0.940

0.001**

TGL

0.073

0.427

TC

0.354

0.001**

HDL

0.989

0.989

VLDL

0.073

0.427

LDL

0.345

0.001**

Figure 1 shows the comparison of serum Leptin between controls and gestational diabetes mellitus. The serum Leptin is significantly elevated in patients with gestational diabetes mellitus when compared with healthy controls

Figure 1

Comparison of serum Leptin between controls and gestational diabetes mellitus

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/20e96951-8544-48ab-b346-52abe8613facimage1.png

Figure 2 shows the scatter plot between Leptin and BMI. The scatter plot reveals a significant positive correlation between Leptin and BMI.

Figure 2

Scatter plot between Leptin and BMI

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/b6526924-b6bb-4d32-b624-4f42bb391864/image/dcf825db-fe5f-4ad0-a82d-cfc18d08d0cd-uimage.png

Figure 3 shows the scatter plot between Leptin and FBS. The scatter plot reveals the significant positive correlation between the Leptin and FBS.

Figure 3

Scatter plot between leptinand fasting blood sugar

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/20e96951-8544-48ab-b346-52abe8613facimage3.png

Figure 4 shows scatter plot between Leptin and HbA1c. There is a relevant significant positive correlation between Leptin and HbA1c.

Figure 4

Scatter plot between Leptin and HbA1c

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/b6526924-b6bb-4d32-b624-4f42bb391864/image/ff25d7f8-2be8-46f4-a201-13e02f471483-uimage.png

Discussion

The current study illustrated how maternal circulating leptin changes during gestational diabetes mellitus. Several studies have reported varying patterns of leptin variation with increasing gestational age in a typical pregnancy.16, 17 The results of this investigation support the hypothesis that GDM and the mother's circulating leptin profile are related. An adaptive reaction to insulin resistance and the inflammatory response linked to GDM could account for the variation in

circulating leptin concentration observed in early gestation between women with and without GDM.18, 19 By directly regulating the insulin receptor or indirectly through central neuronal pathways, leptin may enhance insulin sensitivity and it can also directly promote the absorption of glucose and the synthesis of glycogen in skeletal muscle.20

It was also believed that the upregulation of the leptin gene and protein production constituted a sort of defense mechanism against the imbalance of pro-inflammatory cytokines that occurs in many abnormal pregnancies, including GDM.21 Another case control study also reported significantly elevated levels of leptin was observed in patients with GDM when compared to controls.22 Previous studies also found significant higher levels of leptin was positively correlated with glucose levels during pregnancy.23, 24 Additionally, present study also supports previous studies, because we also observed significant elevated levels of serum leptin and its levels were significant positively correlated with fasting blood sugars and HbA1c.25 Additionally, we also found BMI, total cholesterol and LDL was shown significant and this level was positively correlated with serum leptin. Hence, the present study findings, significant elevated levels of serum leptin might be served as a marker for detection of gestational diabetes mellitus.

Conclusion

Based on the present study findings, we concluded that significant elevated levels of serum leptin might be served as a marker for detection of gestational diabetes mellitus.

Source of Funding

None.

Conflict of Interest

None.

References

1 

W Ye C Luo J Huang C Li Z Liu F Liu Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysisBMJ2022377e067946

2 

BE Metzger TA Buchanan DR Coustan AD Leiva DB Dunger DR Hadden Summary and recommendations of the fifth international workshop-conference on gestational diabetes mellitusDiabetes Care20073025160

3 

XL Gao HX Yang Y Zhao Variations of tumor necrosis factor-alpha, leptin and adiponectin in mid-trimester of gestational diabetes mellitusChin Med J (Engl)200812187015

4 

C Picó M Palou CA Pomar AM Rodríguez A Palou Leptin as a key regulator of the adipose organRev Endocr Metab Disord20222311330

5 

A Pérez-Pérez F Sánchez-Jiménez J Maymó JL Dueñas C Varone V Sánchez-Margalet Role of leptin in female reproductionClin Chem Lab Med20155311528

6 

RB Ceddia HA Koistinen JR Zierath G Sweeney Analysis of paradoxical observations on the association between leptin and insulin resistanceFASEB J20021610116376

7 

N Al-Dahhri WA Bartlett AF Jones S Kumar Role of leptin in glucose metabolism in type 2 diabetesDiabetes Obes Metab20024147e55

8 

VED Knegt PL Hedley JK Kanters IN Thagaard L Krebs M Christiansen The Role of Leptin in Fetal Growth during Pre-EclampsiaInt J Mol Sci20212294569

9 

RA Obeidat N Abdo B Sakee S Alghazo OF Jbarah EA Hazaimeh Maternal and fetal serum leptin levels and their association with maternal and fetal variables and labor: A cross-sectional studyAnn Med Surg (Lond)202172103050

10 

H Laivuori R Kaaja H Koistinen SL Karonen S Andersson V Koivisto Leptin during and after preeclamptic or normal pregnancy: its relation to serum insulin and insulin sensitivityMetabolism200049225963

11 

B Cohen D Novick M Rubinstein Modulation of insulin activities by leptinScience1996274529011858

12 

C Song Y Lyu C Li Long-term risk of diabetes in women at varying durations after gestational diabetes: a systematic review and meta-analysis with more than 2 million womenObes Rev20181934219

13 

A Peltokorpi I Lisinen L Viikari R Kaaja Preconceptual leptin levels in gestational diabetes and hypertensive pregnancyHypertens Pregnancy2022411707

14 

M Lacroix M C Battista M Doyon Higher maternal leptin levels at second trimester are associated with subsequent greater gestational weight gain in late pregnancyBMC Pregnancy Childbirth20161610.1186/s12884-016-0842-y

15 

A Pérez-Pérez A Toro T Vilariño-García J Maymó P Guadix JL Dueñas Leptin action in normal and pathological pregnanciesJ Cell Mol Med201822271627

16 

A Kautzky-Willer G Pacini A Tura C Bieglmayer B Schneider B Ludvik Increased plasma leptin in gestational diabetesDiabetologia200144216472

17 

Screening for Gestational Diabetes: US Preventive Services Task Force Recommendation StatementJAMA202132665318

18 

B Antuna-Puente M Faraj AD Karelis D Garrel D Prud’homme R Rabasa-Lhoret HOMA or QUICKI: is it useful to test the reproducibility of formulas?Diabetes Metab20083432946

19 

N Vitoratus E Salamalekis D Kassanos C Loghis N Panayotopoulos E Kouskouni Maternal plasma leptin levels and their relation to insulin and glucose in gestational onset diabetesGynecol Obstet Invest20015111721

20 

C Qiu MA Williams S Vadachkoria IO Frederick DA Luthy Increased maternal plasma leptin in early pregnancy and risk of gestational diabetes mellitusObstet Gynecol2004103351925

21 

ZJ Liu PQ Liu Y Ding AM Wang JJ Zhang XF Zhao Maternal plasma leptin levels and their relationship to insulin and glucose in pregnant women with gestational diabetes mellitus and gestational impaired glucose toleranceZhonghua Fu Chan Ke Za Zhi20033852613

22 

Z Maghbooli A Hossein-Nezhad M Rahmani AR Shafaei B Larijani Relationship between leptin concentration and insulin resistanceHorm Metab Res200739129037

23 

J Mohiti M Afkhami A Babaei Relation between leptin and insulin in patients with type II diabetes mellitusInt J Endocrinol Metab200531215

24 

M Lappas K Yee M Permezel G E Rice Release and regulation of leptin, resist in and adiponectin from human placenta, fetal membrane, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus complicated pregnanciesJ Endocrinol200518645765

25 

S Soheilykhah M Mojibian S Rahimi-Saghand M Rashidi H Hadinedoushan Maternal serum leptin concentration in gestational diabetesTaiwanese J Obstet Gynecol201150214953



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Original Article


Article page

198-202


Authors Details

Swathy Thilak, Vemugadda Harika*, Radhakrishan Narayanswamy


Article History

Received : 02-02-2024

Accepted : 11-03-2024


Article Metrics


View Article As

 


Downlaod Files